Prescribing trends in veterans with posttraumatic stress disorder

Journal of Clinical Psychiatry

Volumn 73, Issue 3, 2012, Pages 297-303

  Bernardy, Nancy C ^a,b   Lund, Brian C ^c   Alexander, Bruce ^d   Friedman, Matthew J ^a,b  

^a NATIONAL CENTER FOR PTSD   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Iowa City Veterans Affairs Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PRAZOSIN; QUETIAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRAZODONE; ZOLPIDEM;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG USE; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TREATMENT PLANNING; TREND STUDY; VETERAN; VETERANS HEALTH;

EID: 84859154506     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07311     Document Type: Article

References (31)

1. Department of Veterans Affairs, Department of Defense. Clinical practice guideline for management of post-traumatic stress, version 2.0. http://www.healthquality.va.gov/PTSD-FULL-2010c.pdf. Published October 2010. Accessed July 20, 2011.
2. Department of Veterans Affairs, Department of Defense. Clinical practice guideline for the management of post-traumatic stress, version 1.0. http://www.healthquality.va.gov/ptsd/ptsd-full.pdf. Published January 2004. Accessed July 20, 2011.
3. Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry. 1990;51(6):236-238. PubMed (Pubitemid 20209219)
4. Cates ME, Bishop MH, Davis LL, et al. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother. 2004;38(9):1395-1399. doi:10.1345/aph.1E043 PubMed (Pubitemid 39100190)
5. van Minnen A, Arntz A, Keijsers GP. Prolonged exposure inpatients with chronic PTSD: predictors of treatment outcome and dropout. Behav Res Ther. 2002;40(4):439-457. doi:10.1016/S05-7967(01)024-9 PubMed (Pubitemid 34226603)
6. Pollack MH, Hoge EA, Worthington JJ, et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011;72(7):892-897. doi:10.408/JCP.09m05607gry PubMed
7. Mohamed S, Rosenheck RA. Pharmacotherapy of PTSD in the US Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. J Clin Psychiatry. 2008;69(6):959-965. doi:10.408/JCP.v69n061 PubMed (Pubitemid 351944949)
8. Lund BC, Bernardy NC, Alexander B, et al. Declining benzodiazepine use inveterans with posttraumatic stress disorder. J Clin Psychiatry. 2012;73(3):292-296. doi:10.408/JCP.10m0675 PubMed
9. Harpaz-Rotem I, Rosenheck RA. Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs. Arch Gen Psychiatry. 2009;66(4):417-421. doi:10.101/archgenpsychiatry.208.536 PubMed
10. Gravely AA, Cutting A, Nugent S, et al. Validity of PTSD diagnoses in VA administrative data: comparison of VA administrative PTSD diagnoses to self-reported PTSD Checklist scores. J Rehabil Res Dev. 2011;48(1):21-30. doi:10.1682/JRD.209.08.016 PubMed
11. Lund BC, Abrams TE, Gravely AA. Rebuttal toGravely et al. Validity of PTSD diagnoses in VA administrative data: comparison of VA administrative PTSD diagnoses to self-reported PTSD Checklist scores. J Rehabil Res Dev. 2011;48(5):vii-ix. PubMed
12. Clark NA, Alexander BA. Increased rate of trazodone prescribing with bupropion and selective serotonin-reuptake inhibitors versus tricyclic antidepressants. Ann Pharmacother. 2000;34(9):1007-1012. doi:10.1345/aph.19101 PubMed (Pubitemid 30660776)
13. Forbes D, Creamer M, Bisson JI, et al. A guide toguidelines for the treatment of PTSD and related conditions. J Trauma Stress. 2010;23(5): 537-552. doi:10.102/jts.20565 PubMed
14. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283(14):1837-1844. doi:10.101/jama.283.14.1837 PubMed (Pubitemid 30207620)
15. Davidson JRT, Pearlstein T, Londborg P, et al. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry. 2001;158(12): 1974-1981. doi:10.176/api.ajp.158.12.1974 PubMed (Pubitemid 33104101)
16. Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-1988. doi:10.176/api.ajp.158.12.1982 PubMed (Pubitemid 33104102)
17. Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206. doi:10.408/JCP.v63n0305 PubMed (Pubitemid 34407078)
18. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-868. doi:10.408/JCP.v62n105 PubMed (Pubitemid 33131172)
19. Friedman MJ, Davidson JRT, Stein DJ. Pharmacotherapy for Adults. In: Foa EG, Keane TM, Friedman MJ, et al, eds. Effective Treatments for PTSD: Practice Guidelines From the International Society for Traumatic Stress Studies. 2nd ed. New York, NY: Guilford Press; 2009:245-268.
20. Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007;27(2):193-197. doi:10.1097/JCP.0b013e318032eaed PubMed (Pubitemid 46594938)
21. Wilens TE, Haight BR, Horrigan JP, et al. Bupropion XLin adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57(7):793-801. doi:10.1016/j.biopsych.205.01.027 PubMed (Pubitemid 40487924)
22. Raupach T, van Schayck CP. Pharmacotherapy for smoking cessation: current advances and research topics. CNS Drugs. 2011;25(5):371-382. doi:10.2165/1590620-0-0 PubMed
23. Wiegand MH, Landry F, Brückner T, et al. Quetiapine in primary insomnia: a pilot study. Psychopharmacology (Berl). 2008;196(2):337-338. doi:10.107/s0213-07-0968-8 PubMed
24. Peterlin BL, Rosso A, Sheftell F, et al. Post-traumatic stress disorder, drug abuse and migraine: new findings from the National Comorbidity Survey Replication (NCS-R). Cephalalgia. 2011;31(2):235-244. PubMed
25. Hamner M, Canive J, Robert S, et al. Quetiapine monotherapy in chronic posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial. Poster presentation at the 29th Annual Meeting of the Anxiety Disorders Association of America; March 12-15, 2009; Santa Ana Pueblo, NM.
26. Krystal JH, Rosenheck RA, Cramer JA, et al Veterans Affairs Cooperative Study No. 504 Group. Adjunctive risperidone treatment for antidepressant- resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi:10.101/jama.201.1080 PubMed
27. Miller LJ. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances. Pharmacotherapy. 2008;28(5):656-666. doi:10.1592/phco.28.5. 656 PubMed (Pubitemid 351620032)
28. Byers MG, Allison KM, Wendel CS, et al. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol. 2010;30(3):225-229. doi:10.1097/JCP.0b013e3181dac52f PubMed
29. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12): 1048-1060. doi:10.101/archpsyc.195.039502406012 PubMed
30. Karlin BE, Ruzek JI, Chard KM, et al. Dissemination of evidence-based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration. J Trauma Stress. 2010;23(6):663-673. doi:10.102/jts.2058 PubMed
31. Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep. 2006;29(11):1398-1414. PubMed (Pubitemid 44764665)